US representatives are pressing genetic testing companies for details on their security systems and customer privacy policies.
Genomic data can have a significant effect on other areas of society. Insurance premiums, familial impact, identification. As we enter the genomic era, policy will need to reflect these new considerations.
The Nuffield Council on Bioethics has concluded that using gene editing tools on human embryos, sperm, or eggs for heritable gene editing could be ‘morally permissible’ in some cases.
Dr. Mark McClellan joined Johnson & Johnson’s board of directors after leaving the FDA, but the connection often isn’t mentioned in research papers or public events.
Founded in 1790, the Patent Office aimed to put innovation and entrepreneurship within reach of every citizen. Now, 10 million patents later, critics say an out-of-touch system is doing the opposite.
The US Health and Human Services Secretary Alex Azar has approved adding a test for spinal muscular atrophy to the list of recommended newborn screens in the United States.
China’s government is prioritising world-class science and tech. An expert describes the Chinese research landscape – and questions its sustainability.
The California State Legislature has approved a budget including $2 million for a pilot project to fund clinical whole genome sequencing as a first line diagnostic test.
The U.S. Food and Drug Administration has approved the first drug derived from Marijuana to treat two rare and severe forms of epilepsy. Will the U.K. follow?
A report has highlighted the potential misuses of synthetic biology for biological warfare with recommendations of how we might prepare for and prevent biological attacks.
The U.S. Patent and Trademark Office has decided to grant not just one, but two new CRISPR patents to UC Berkeley, home of pioneer Jennifer Doudna, who many consider the creator of the technology.
The Wellcome Sanger Institute has provided evidence and made recommendations for an inquiry by the UK Parliament Science and Technology Committee into an immigration system that works for science and innovation, following Brexit.
Elizabeth Holmes, Founder of disgraced biotech Theranos, and her former COO, Ramesh ‘Sunny’ Balwani, have been indicted with alleged wire fraud schemes in the state of California.